You're reading: Wall Street Journal: Moderna eyes dual Covid-19, flu vaccine

Wall Street Journal: Moderna eyes dual Covid-19, flu vaccine

Published March 24, 2021 at 3:44 am

A medical worker prepares a dose of Moderna vaccine against the COVID-19 on March 13, 2021 at the local health authority (ASL) offices in Dronero, Maira Valley, near Cuneo, Northwestern Italy, as part of a home vaccination campaign with the Moderna vaccine against COVID-19 for residents over 80-years-old.

Photo by AFP

Moderna Inc. Chief Executive Stephane Bancel said the company is developing a vaccine targeting both seasonal flu and Covid-19 that, if successful, would protect recipients from both illnesses. Mr. Bancel said Tuesday that the shot could be ready for use in a couple of years, a timeline dictated by both the company’s progress and the regulatory process.